Gary D. Rubin - Jan 1, 2023 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role: Director, 10%+ Owner
Signature: /s/ Gary D. Rubin
Stock symbol: BIAF
Transactions as of: Jan 1, 2023
Transactions value $: $56,255
Form type: 4
Date filed: 7/6/2023, 04:15 PM
Previous filing: Oct 21, 2022
Next filing: Jan 24, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIAF	Common Stock	Award	$18.8K	+8.23K	+15.95%	$2.28	59.8K	Jan 1, 2023	Direct	F1
transaction	BIAF	Common Stock	Award	$18.7K	+9.92K	+16.58%	$1.89	69.7K	Apr 15, 2023	Direct	F2
transaction	BIAF	Common Stock	Award	$18.7K	+10.2K	+14.69%	$1.83	80K	Jul 1, 2023	Direct	F3
holding	BIAF	Common Stock						1.58M	Jan 1, 2023	By Trust	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant from bioAffinity Technologies, Inc. (the "Issuer") to Mr. Rubin of 8,227 restricted shares of common stock, par value $0.007 (the "Common Stock"), on January 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.
F2	Represents a grant from the Issuer to Mr. Rubin of 9,920 restricted shares of Common Stock on April 15, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest one-third on the date of grant, one-third on May 1, 2023 and the remaining shares on June 1, 2023, provided Mr. Rubin continues to serve as a director, and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.
F3	Represents a grant from the Issuer to Mr. Rubin of 10,245 restricted shares of Common Stock, on July 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.
F4	Represents shares of Common Stock owned directly by the Harvey Sandler Revocable Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. Rubin, as co-trustee of the Trust, which indirect ownership was previously reported on a Form 4 filed by Mr. Rubin and the Trust on October 21, 2022. Mr. Rubin disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.